Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 36

Triana Biomedicines emerges with $110m

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

Apr 11, 2022

Daily Deal Round Up: April 8, 2022

Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.

Apr 8, 2022

HIF Global pumps in $260m

Porsche, Baker Hughes and majority shareholder AME all invested in the round, which will support the deployment of HIF's hydrogen fuel projects.

Apr 8, 2022

Binance.US rakes in $200m

The cryptocurrency exchange’s US spinoff pulled in a nine-figure sum from investors like Circle Ventures at a post-money valuation of $4.7bn.

Apr 8, 2022

Fetch Rewards retrieves $240m

SoftBank, TelevisaUnivision and NielsenIQ helped provide the customer loyalty app developer with fresh capital in a round more than doubling its valuation to $2.5bn.

Apr 8, 2022

Sky Mavis scores $150m

Binance and Animoca Brands were among the investors helping the blockchain game developer pay back users that recently fell victim to the Ronin security breach.

Apr 8, 2022

Metis makes space for $150m

China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.

Apr 8, 2022

Xmov executes $130m in funding

SoftBank Vision Fund 2 co-led the virtual avatar infrastructure builder’s $110m series C round, which emerged alongside a $20m series B featuring new and returning investors.

Apr 8, 2022

Deal net: April 8, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 8, 2022

Daily Deal Round Up: April 7, 2022

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

Apr 7, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here